Trump’s Drug Order Is A Wake-Up Call For India’s Pharma Policy Trump’s price cap move may trigger global pressure on India to dilute its patent regime. New FTAs show signs of troubling concessions.

For a detailed analysis, read Ajay Srivastava's article: basispointinsight.com/Story/Econom...

#PharmaSovereignty #HealthForAll #IPRPressure #AffordableMeds #GlobalHealthJustice #FTAWatch